ArticleNature2024
Author Correction: Genotyping, sequencing and analysis of 140,000 adults from Mexico City.
Abstract readPublished Erratum
In one paragraph
Article in Nature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
49 authors.
Andrey Ziyatdinov *Regeneron Genetics Center, Tarrytown, NY, USA.
Jason Torres *Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. jason.torres@ndph.ox.ac.uk.ORCID http://orcid.org/0000-0002-7537-7035
Jesús Alegre-Díaz *Experimental Research Unit from the Faculty of Medicine (UIME), National Autonomous University of Mexico (UNAM), Mexico City, Mexico.ORCID http://orcid.org/0000-0001-9390-3871
Joshua BackmanRegeneron Genetics Center, Tarrytown, NY, USA.ORCID http://orcid.org/0000-0001-7262-0880
Joelle MbatchouRegeneron Genetics Center, Tarrytown, NY, USA.ORCID http://orcid.org/0000-0002-2245-3743
Michael TurnerClinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-0351-4053
Sheila M GaynorRegeneron Genetics Center, Tarrytown, NY, USA.
Tyler JosephRegeneron Genetics Center, Tarrytown, NY, USA.
Yuxin ZouRegeneron Genetics Center, Tarrytown, NY, USA.ORCID http://orcid.org/0000-0001-9816-5847
Daren LiuRegeneron Genetics Center, Tarrytown, NY, USA.
Rachel WadeClinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-9826-6322
Jeffrey StaplesRegeneron Genetics Center, Tarrytown, NY, USA.
Razvan PaneaRegeneron Genetics Center, Tarrytown, NY, USA.
Alex PopovRegeneron Genetics Center, Tarrytown, NY, USA.
Xiaodong BaiRegeneron Genetics Center, Tarrytown, NY, USA.
Suganthi BalasubramanianRegeneron Genetics Center, Tarrytown, NY, USA.
Lukas HabeggerRegeneron Genetics Center, Tarrytown, NY, USA.
Rouel LancheRegeneron Genetics Center, Tarrytown, NY, USA.
Alex LopezRegeneron Genetics Center, Tarrytown, NY, USA.
Evan MaxwellRegeneron Genetics Center, Tarrytown, NY, USA.
Marcus JonesRegeneron Genetics Center, Tarrytown, NY, USA.
Humberto García-OrtizInstituto Nacional de Medicina Genómica, Tlalpan, Mexico City, Mexico.ORCID http://orcid.org/0000-0002-0453-980X
Raul Ramirez-ReyesExperimental Research Unit from the Faculty of Medicine (UIME), National Autonomous University of Mexico (UNAM), Mexico City, Mexico.ORCID http://orcid.org/0000-0001-9763-324X
Rogelio Santacruz-BenítezExperimental Research Unit from the Faculty of Medicine (UIME), National Autonomous University of Mexico (UNAM), Mexico City, Mexico.
Abhishek NagCentre for Genomics Research, Discovery Sciences, Research and Development Biopharmaceuticals, AstraZeneca, Cambridge, UK.
Katherine R SmithCentre for Genomics Research, Discovery Sciences, Research and Development Biopharmaceuticals, AstraZeneca, Cambridge, UK.ORCID http://orcid.org/0000-0002-0329-5938
Amy DamaskRegeneron Genetics Center, Tarrytown, NY, USA.
Nan LinRegeneron Genetics Center, Tarrytown, NY, USA.
Charles PauldingRegeneron Genetics Center, Tarrytown, NY, USA.ORCID http://orcid.org/0000-0002-7918-3561
Mark ReppellAbbVie, North Chicago, IL, USA.ORCID http://orcid.org/0000-0001-7992-4537
Sebastian ZöllnerDepartment of Biostatistics, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0001-7362-156X
Eric JorgensonRegeneron Genetics Center, Tarrytown, NY, USA.ORCID http://orcid.org/0000-0002-5829-8191
William SalernoRegeneron Genetics Center, Tarrytown, NY, USA.
Slavé PetrovskiCentre for Genomics Research, Discovery Sciences, Research and Development Biopharmaceuticals, AstraZeneca, Cambridge, UK.ORCID http://orcid.org/0000-0002-1527-961X
John OvertonRegeneron Genetics Center, Tarrytown, NY, USA.
Jeffrey ReidRegeneron Genetics Center, Tarrytown, NY, USA.ORCID http://orcid.org/0000-0001-8645-4713
Timothy A ThorntonRegeneron Genetics Center, Tarrytown, NY, USA.ORCID http://orcid.org/0000-0001-7071-2642
Gonçalo AbecasisRegeneron Genetics Center, Tarrytown, NY, USA.ORCID http://orcid.org/0000-0003-1509-1825
Jaime BerumenExperimental Research Unit from the Faculty of Medicine (UIME), National Autonomous University of Mexico (UNAM), Mexico City, Mexico.ORCID http://orcid.org/0000-0001-6707-3317
Lorena Orozco-OrozcoInstituto Nacional de Medicina Genómica, Tlalpan, Mexico City, Mexico.ORCID http://orcid.org/0000-0002-5801-9180
Rory CollinsClinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Regeneron Genetics Center
Mexico City Prospective Study
Aris BarasRegeneron Genetics Center, Tarrytown, NY, USA.ORCID http://orcid.org/0000-0002-6830-3396
Michael R HillClinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Jonathan R EmbersonClinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-7792-9422
Jonathan MarchiniRegeneron Genetics Center, Tarrytown, NY, USA. jonathan.marchini@regeneron.com.ORCID http://orcid.org/0000-0003-0610-8322
Pablo Kuri-MoralesInstituto Tecnológico y de Estudios Superiores de Monterrey, Monterrey, Mexico.ORCID http://orcid.org/0000-0002-0704-9507
Roberto Tapia-ConyerFaculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico. tapiaconyer@gmail.com.ORCID http://orcid.org/0000-0003-3814-2904
Funding
Medical Research Council MR/Z504543/1
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.